Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Fish and Richardson
Mallinckrodt
Teva
Healthtrust
Farmers Insurance
Accenture
Merck

Generated: November 13, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: abacavir sulfate

« Back to Dashboard

abacavir sulfate Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Cipla Limited abacavir sulfate; lamivudine 202007 60MG; 30MG TABLET, FOR SUSPENSION; ORAL
Mylan Labs abacavir sulfate; lamivudine 202381 60MG; 30MG TABLET; ORAL
Matrix Labs Ltd abacavir sulfate; lamivudine 090519 600MG; 300MG TABLET; ORAL
Aurobindo Pharma abacavir sulfate; lamivudine 090159 EQ 600MG BASE; 300MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKinsey
Cipla
US Army
Mallinckrodt
Cantor Fitzgerald
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.